Catalog No.
YHJ99802
Expression system
E. coli
Species
Homo sapiens (Human)
Protein length
Ala2-Lys200
Predicted molecular weight
33.95 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
Q9UHK6
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
AMACR, Alpha-methylacyl-CoA racemase, 2-methylacyl-CoA racemase
Immunostaining for polycomb group protein EZH2 as a diagnostic tool to differentiate urothelial carcinoma in situ from benign lesions., PMID:40456417
Primary urethral adenocarcinoma harbors recurrent KRAS and EGFR alterations., PMID:40194726
Eosinophilic solid and cystic renal cell carcinoma: A case with two novel TSC2 mutations., PMID:40174278
Unveiling the enigma: Thyroid-like follicular carcinoma of the left kidney., PMID:40143489
Exploring the efficacy of AMACR, ERG, and AR immunostains in prostatic adenocarcinoma and their association with novel grade groups., PMID:39931952
Cytomorphology and clinicopathologic correlation of TFE3-rearranged renal cell carcinoma., PMID:39912368
Atypical Metastases from Prostate Cancer: Alpha-Methylacyl-Coenzyme A Racemase (AMACR) as a Potential Molecular Target in Prostate-Specific Membrane Antigen-Negative Prostate Adenocarcinoma., PMID:39858412
[Aggressive mucinous tubular and spindle cell carcinoma of the kidney: a clinicopathological and genetic analysis of four cases]., PMID:39762168
Eplerenone, a mineralocorticoid receptor inhibitor, reduces cirrhosis associated changes of hepatocyte glucose and lipid metabolism., PMID:39707386
Combining tissue biomarkers with mpMRI to diagnose clinically significant prostate cancer. Analysis of 21 biomarkers in the PICTURE study., PMID:39578642
Comparative Study of Gleason 7 (3+4) and (4+3) Prostatic Adenocarcinomas with Prognostic Criteria and Immunohistochemical Profiles of AMACR, PSA and Ki-67., PMID:39388614
Peroxisomal leukodystrophy., PMID:39322376
A comparative study of 18F-PSMA-1007 PET/CT and pelvic MRI in newly diagnosed prostate cancer., PMID:39080625
Ki-67 distribution, α-methylacyl-CoA racemase (AMACR) expression and mucin phenotypes are associated with non-polypoid growth in ulcerative colitis-associated neoplasia., PMID:39031700
Multiplexed Opto-Microfluidic Biosensing: Advanced Platform for Prostate Cancer Detection., PMID:38683677
Tumor promoting effect of spheroids in an orthotopic prostate cancer mouse model., PMID:38632341
Serum Fusion Transcripts to Assess the Risk of Hepatocellular Carcinoma and the Impact of Cancer Treatment through Machine Learning., PMID:38537933
Biphasic papillary (biphasic squamoid alveolar) renal cell carcinoma: a clinicopathologic and molecular study of 17 renal cell carcinomas including 10 papillary adenomas., PMID:38388964
Tumor microenvironment deconvolution identifies cell-type-independent aberrant DNA methylation and gene expression in prostate cancer., PMID:38173042
Analysis of enzyme reactions using NMR techniques: A case study with α-methylacyl-CoA racemase (AMACR)., PMID:37858529
Expression of nectin-4 in prostate cancer., PMID:37829757
Papillary renal neoplasm with reverse polarity: a clinicopathologic study of 43 cases with a focus on the expression of KRAS signaling pathway downstream effectors., PMID:37797754
Diagnostic Roles of Immunohistochemical Markers CK20, CD44, AMACR, and p53 in Urothelial Carcinoma In Situ., PMID:37763728
Immunohistochemical Expression of Alpha-Methyl-Coa (AMACR) and ERG in Prostatic Adenocarcinoma and Prostatic Hyperplasia: A Comparative Study., PMID:37642075
Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer., PMID:37634036
Novel Histopathological Biomarkers in Prostate Cancer: Implications and Perspectives., PMID:37371647
Analysis of kidney proteomes to identify biological pathways associated with vancomycin-induced nephrotoxicity in mice by tandem mass tag-labeled quantitative and parallel reaction monitoring phosphoproteomics., PMID:37340591
DIAGNOSTIC UTILITY OF IMMUNOHISTOCHEMICAL EXPRESSION OF KI!67, P63 AND AMACR IN PROSTATE INTRAEPITHELIAL NEOPLASIA., PMID:37010182
A comprehensive immunohistochemical analysis of 26 markers in 250 cases of serous ovarian tumors., PMID:36855066
Early Cell Cultures from Prostate Cancer Tissue Express Tissue Specific Epithelial and Cancer Markers., PMID:36769153
SATB2 as a Marker of the Proximal Nephron: Expression in Nephrogenic Adenoma and Correlation With Other Renal Tubular Markers., PMID:36744623
Accurate prostate cancer detection based on enrichment and characterization of prostate cancer specific circulating tumor cells., PMID:36718027
18F-DCFPyL (PSMA) PET as a radiotherapy response assessment tool in metastatic prostate cancer., PMID:36713978
Expanding the prostate cancer cell line repertoire with ACRJ-PC28, an AR-negative neuroendocrine cell line derived from an African-Caribbean patient., PMID:36643868
An MGMT Allelic Variant Can Affect Biochemical Relapse in Prostate Cancer Patients., PMID:36585213
AMACR Expression is a Potential Diagnostic Marker in Apocrine Lesions of Breast, and is Associated with High Histologic Grade and Lymph Node Metastases in Some Invasive Apocrine Breast Cancers., PMID:36577560
Clear cell renal cell carcinoma with focal psammomatous calcifications: a rare occurrence mimicking translocation carcinoma., PMID:36564980
Advantages and limitations of 3D organoids and ex vivo tumor tissue culture in personalized medicine for prostate cancer., PMID:36513514
Sustained release of alpha-methylacyl-CoA racemase (AMACR) antibody-conjugated and free doxorubicin from silica nanoparticles for prostate cancer cell growth inhibition., PMID:36314600
[Oncocytic papillary renal cell carcinoma: a clinicopathological analysis of nineteen cases]., PMID:36207910
Alpha-methylacyl-CoA racemase (AMACR) protein is upregulated in early proliferative lesions of the breast irrespective of apocrine differentiation., PMID:35998819
TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms., PMID:35980471
Anti-tumor activity of a T-helper 1 multiantigen vaccine in a murine model of prostate cancer., PMID:35948756
Mucinous adenocarcinoma of the prostatic urethra after brachytherapy for prostatic adenocarcinoma: a case series., PMID:35926810
"Papillary Adenoma-like" Renal Tumor with TFE3 Gene Rearrangement, A Potential Precursor to or Early Event in the Development of TFE3 Translocation Renal Cell Carcinoma., PMID:35850545
Y-shaped DNA nanostructures assembled-spherical nucleic acids as target converters to activate CRISPR-Cas12a enabling sensitive ECL biosensing., PMID:35780537
ALK rearrangement-associated renal cell carcinoma morphologically mimicking mucinous tubular and spindle cell carcinoma: a case report., PMID:35718773
P504S/alpha-methylacyl-CoA racemase, HNF1β and napsin A in morular metaplasia and clear cell carcinoma of the endometrium: An immunohistochemical analysis., PMID:35696768
Analysis of clinicopathological and molecular features of ELOC(TCEB1)-mutant renal cell carcinoma., PMID:35653922
For research use only. Not for human or drug use.
